News Related to Nivolumab

Related coverage linked through entity extraction aliases.

Immunotherapy Plus Chemotherapy Before Surgery Shows Promise for Pancreatic Cancer

Feb 18, 2026

A UCLA clinical trial found that adding immunotherapy to chemotherapy before surgery is safe for borderline-resectable pancreatic cancer patients, with a subset experiencing deep, durable responses including complete tumor regression.

FDA Approves KEYTRUDA for Platinum-Resistant Ovarian Cancer

Feb 15, 2026

The FDA approved KEYTRUDA and its subcutaneous QLEX formulation for platinum-resistant ovarian cancer, marking the first PD-1 inhibitor cleared for this patient population based on Phase 3 results.